Sebastia-Amat Sergio, Tortosa-Martínez Juan, Pueo Basilio
Health, Physical Activity and Sports Technology (HEALTH-TECH), Department of General and Specific Didactics, Faculty of Education, University of Alicante, 03690 Alicante, Spain.
J Clin Med. 2025 Jan 9;14(2):361. doi: 10.3390/jcm14020361.
: Parkinson's disease (PD) is a neurodegenerative disorder that significantly impairs motor function, leading to mobility challenges and an increased risk of falls. Current assessment tools often inadequately measure the complexities of motor impairments associated with PD, highlighting the need for a reliable tool. This study introduces the Motor Assessment Timed Test (MATT), designed to assess functional mobility in PD patients. : A cross-sectional study was conducted involving 57 participants (38 men and 19 women) aged 44 to 84, diagnosed with idiopathic PD. Participants were recruited from three PD associations and underwent a series of assessments, including MATT, to evaluate gait, balance, and dual-task performance under conditions that reflect real-life challenges faced by individuals with PD. : MATT demonstrated excellent reliability with intra-rater reliability (ICC = 0.99), inter-rater reliability (ICC = 0.96-0.99), and test-retest reliability (ICC = 0.93-0.99). The coefficient of variation for total time and each segment ranged from 4.73% to 13.71%, indicating consistent performance across trials. The concurrent validity showed very high correlations with established tools such as the Timed Up and Go (TUG) test (ρ = 0.86, < 0.001) and the Berg Balance Scale (BBS) (ρ = -0.83, < 0.001), among others. Only 7.3% of participants reported difficulties in understanding the MATT, predominantly those in advanced stages of the disease. In addition, 23.6% of participants experienced significant challenges in performing the test, particularly individuals with lower Mini-Mental State Examination (MMSE) scores (≤ 26) and more advanced disease progression. : MATT is a promising tool for assessing motor complications in PD, offering a comprehensive evaluation of functional mobility. Its implementation in clinical practice could enhance the management of PD, facilitating tailored interventions and improving patient outcomes.
帕金森病(PD)是一种神经退行性疾病,会严重损害运动功能,导致行动不便并增加跌倒风险。当前的评估工具往往无法充分衡量与PD相关的运动障碍的复杂性,这凸显了对可靠工具的需求。本研究引入了运动评估定时测试(MATT),旨在评估PD患者的功能性活动能力。
开展了一项横断面研究,纳入了57名年龄在44至84岁之间、被诊断为特发性PD的参与者(38名男性和19名女性)。参与者从三个PD协会招募,并接受了一系列评估,包括MATT,以评估在反映PD患者面临的现实生活挑战的条件下的步态、平衡和双任务表现。
MATT表现出出色的可靠性,内部评分者信度(ICC = 0.99)、评分者间信度(ICC = 0.96 - 0.99)和重测信度(ICC = 0.93 - 0.99)。总时间和每个部分的变异系数范围为4.73%至13.71%,表明各次试验的表现一致。同时效度显示,与定时起立行走(TUG)测试(ρ = 0.86,< 0.001)和伯格平衡量表(BBS)(ρ = -0.83,< 0.001)等既定工具具有非常高的相关性。只有7.3%的参与者表示理解MATT有困难,主要是疾病晚期的患者。此外,23.6%的参与者在进行测试时遇到了重大挑战,特别是简易精神状态检查表(MMSE)得分较低(≤ 26)且疾病进展较严重的个体。
MATT是评估PD运动并发症的一个有前景的工具,可对功能性活动能力进行全面评估。在临床实践中应用它可以加强PD的管理,促进针对性干预并改善患者预后。